I am liking what i'm seeing at the JPMorgan Healthcare Conference, says Jim Cramer Massive and dense structures have been ...

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...

Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent acquisitions, growth in its vaccine segment, opportunities in China and more.

Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.

Sodali & Co, the global advisory firm owned by TPG, has named Andrew Benett as chief executive, a source tells DD. He previously worked at Havas Creative Group and Bloomberg Media.

JPMorgan's stock came under pressure as lower rates would have hampered its top-line growth. Further, the company, on its third-quarter conference call, projected lower interest rates would hurt ...

READ ALSO: 10 AI Stocks Taking Wall Street by Storm and Top 10 AI Stocks on Latest News and Analyst Ratings Speaking at Russia’s flagship AI conference ... December 11, JP Morgan downgraded ...

We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where C3.ai, Inc. (NYSE:AI)) stands against other top AI news you shouldn’t miss.

READ ALSO: 10 AI Stocks Taking Wall Street by Storm and Top 10 AI Stocks on Latest News and Analyst Ratings Speaking at Russia’s flagship AI conference last week ... of the world are the United States ...

and China may raise costs, hurt supply chains, and invite retaliation, heightening stagflation fears. Economists highlight the potential for market pushback on Trump’s policies, with mixed effects on ...

From Silicon Valley’s biggest names to streaming giants, the US election has prompted the nation’s business behemoths to ...

SAN FRANCISCO and SUZHOU, China, Jan. 5, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...